Amgen, Inc. 1996. Amgen Fact Sheet. Electronic ed. <http://www.amgen.com>. Thousand Oaks: Amgen, Inc.

Animal and Plant Health Inspection Service (APHIS). 1995. Genetically engineered organisms and products; simplification of requirements and procedures for genetically engineered organisms. Federal Register, 80(162): 43567-73.

Anonymous. n.d. (1994). The Need for a Biosafety Protocol as Part of the Convention on Biological Diversity. World Wide Fund for Nature (WWF) International.

Anonymous. 1995. Transgenic Fish: the Next Threat to Marine Biodiversity. Washington, D.C.: Community Nutrition Institute.

Athanasiou, T. 1996. Divided Planet: The Ecology of Rich and Poor. Boston: Little, Brown & Co.

Barry, T. 1995. Zapata's Revenge: Free Trade and the Farm Crisis in Mexico. Boston: South End Press.

Boeing Company. 1996. Quick Facts about Boeing. Electronic ed. <http://www.boeing.com/quick.facts.html>. Seattle: Boeing Co.

Carey, J. 1994. Gene therapy: promises, promises. Business Week, 3391 (September 26, 1994): 92.

Chomsky, N. 1994. World Orders, Old and New. New York: Columbia University Press.

Coghlan, A. 1995. "Herd instinct" drove biotech firms to the brink. New Scientist, 148(2000): 7.

Crucible Group. 1994. People, Plants, and Patents: The Impact of Intellectual Property on Trade, Plant Biodiversity, and Rural Society. Ottawa: International Development Research Center.

Eisenberg et al. 1993. Unconventional medicine in the United States; prevalence, costs and patterns of use. New England Journal of Medicine, 328: 246-252

Ewing, T. 1996. Monsanto Plans to Cut up to 2,500 Jobs after Spinoff of its Chemical Business. Wall Street Journal, 10 December 1996: A4.

Fincham, J.R.S. and J.R. Ravetz. 1991. Genetically Modified Organisms: Benefits and Risks. Toronto: University of Toronto Press.

Food and Drug Administration (FDA). 1996. FDA Grants Accelerated Approval of Third Protease Inhibitor. Press release, March 14, 1996.

Fowler, C. 1994. Unnatural Selection: Technology, Politics, and Plant Evolution. International Studies in Global Change, no 6. Langhorne, PA: Gordon & Breach.

Fox, J.L. 1996a. Bt cotton infestations renew resistance concerns. Nature Biotechnology, 14(9): 1070.

Fox, J.L. 1996b. Surreal US budget again favors R&D spending. Nature Biotechnology, 14(5): 562-3.

Glaser, V. 1995. U.S. biopharm firms up R&D spending 35%. Bio/Technology, 13(7): 632-5.

Haber, E. 1996. Industry and the university. Nature Biotechnology, 14(4): 441-2.

Hamilton, J. O'C. 1994. Biotech: an industry crowded with players faces and ugly reckoning. Business Week, 3391 (September 26, 1994): 84-92.

Harvey, D. 1990. The Condition of Postmodernity. Cambridge, MA: Blackwell Publishers, Inc.

Hobbelink, H. 1995. Biotechnology and the future of agriculture. In Biopolitics: A Feminist and Ecological Reader on Biotechnology. (V. Shiva and I. Moser eds). London: Zed Books Ltd. pp. 226-33.

Hodgson, J. 1995. From little acorns É plant biotechnology blossoms in the Balkans. Bio/Technology, 13(8): 760-1.

Hodgson, J. 1996a. Bulgaria gets eastern Europe's first gene release body. Nature Biotechnology, 14(10): 1212.

Hodgson, J. 1996b. Companies earn $10 billion of biotech's $30 billion. Nature Biotechnology, 14(5): 560-1.

Holmes, T.M. and E.R. Ingham. 1994. The effects of genetically engineered micro-organisms on soil food webs. In Supplement to the Bulletin of the Ecological Society of America (Abstracts of the 79th Annual ESA Meeting; Science and Public Policy, Knoxville, TN, 7-11 August 1994).

Juma, C. 1989. The Gene Hunters: Biotechnology and the Scramble for Seed.Princeton: Princeton University Press.

Kapuscinski, A.R. and E.M. Hollerman. 1990. Transgenic fishes (AFS Position Statement). Fisheries, 15(4): 2-5.

Kidd, G. 1995. 14 U.S. agbiotech firms up R&D spending 3.2%. Bio/Technology, 13(8): 732-3.

Kimbrell, A. 1993. The Human Body Shop: The Engineering and Marketing of Life. San Francisco: Harper-Collins Publishers.

Lacey, R.W. and J. Heritage. 1994. Safety Issues Associated with the Use of Transgenic Organisms. University of Leeds.

Linck, N.J. and S.A. Chambers. 1995. Utility in biotech patent applications: new guidelines should offer relief for biotech patent applications rejected because they lack "utility." Bio/Technology, 13(9): 962-4. Massachusetts Breast Cancer Coalition (MBCC). 1996. What You Need to Know Before Considering Genetic Testing for Heritable Breast Cancer (fact sheet).

McCullum, C. 1995. The New Biotechnology Era: Issues for Nutrition Policy. Washington, D.C.: Community Nutrition Institute.

Ministry of International Trade and Industry (MITI). 1996. Outline of Policy Guidelines for FY 1997. <http://www.jef.or.jp/news/n9644.html>. Tokyo: MITI.

Monsanto Company. 1992. The New Biology: The Science and Its Applications. St Louis: Monsanto Co.

Monsanto Company. 1996a. Annual Report to Investors. Electronic ed. <http://www.monsanto.com>. St Louis: Monsanto Co.

Monsanto Company. 1996b. Monsanto to Create Separate Life Sciences and Chemical Companies via Spin-off; Announces Reserve. Press release, December 9, 1996.

Monsanto Company. 1997. Monsanto Reaches Agreements to Acquire Holden's, Corn States and Corn States International; Complementary Technologies Important to Monsanto's Life Sciences Business. Press release, January 6, 1997.

Munasinghe, K. 1996. Searching the patent pipeline. Nature Biotechnology, 14(9): 1165-6.

National Research Council (NRC). 1989. Alternative Agriculture. Washington, D.C.: National Academy Press.

Newman, S.A. 1989. Genetic engineering as metaphysics and menace. Science and Nature, 9/10. Essays in the History of Environmental Science series. London: British Society for the History of Science.

Nijar, G.S. n.d. (1995) TRIPs and Biodiversity: The Threat and Responses--a Third World View. Penang: Third World Network.

Nordlee, J.A. et al. 1996. Identification of Brazil-nut allergen in transgenic soybeans. New England Journal of Medicine, 334(11): 688-92.

Office of Technology Assessment (U.S. Congress, OTA). 1991. Biotechnology in a Global Economy. Washington, D.C.: U.S. Government Printing Office.

Persidis, A. and A. Persidis. 1996. Biotechnology consortia versus multifirm alliances: paradigm shift at work? Nature Biotechnology, 14(12): 1657-60.

Rissler, J. and M. Mellon. 1993. Perils Amidst the Promise: Ecological Risks of Transgenic Crops in a Global Market. Cambridge, MA: Union of Concerned Scientists.

Rissler, J. and M. Mellon. 1996. The Ecological Risks of Engineered Crops. Cambridge, MA: MIT Press.

Saltus, R. 1996. Gene test for cancer risk is offered: some geneticists doubt its value. Boston Globe, October 25, 1996: A1.

Seabrook, J. 1993. What is development? Voices from the South. In Victims of Development: Resistance and Alternatives. London: Verso.

Shiva, V. 1991. The Violence of the Green Revolution: Third World Agriculture, Ecology and Politics. London: Zed Books Ltd.

Shiva, V. 1993. Monocultures of the Mind. Penang: Third World Network.

Soleri, D. et al. 1994. Gifts from the Creator: intellectual property rights and folk crop varieties. In Intellectual Property Rights and Indigenous Peoples: A Source Book. (T. Greaves ed.) Oklahoma City: Society for Applied Anthropology. pp. 21-40.

Talman, S. and H. Puckey. 1993. Bio-engineered drug kills 38, harms thousands. Third World Resurgence, 38: 19.

Taylor, L. and U. Pieper. 1996. Reconciling Economic Reform and Sustainable Development: Social Consequences of Neo-Liberalism. Office of Development Studies: Discussion Paper Series, no 2. New York: United Nations Development Programme.

United Nations Development Programme (UNDP). 1992. Human Development Report 1992. New York: Oxford University Press.

United Nations Development Programme (UNDP). 1996. Human Development Report 1996. New York: Oxford University Press.

Weiss, R. 1995b. Scientists report the first success of "gene therapy": experimental technique helps defeat immune-system ailment. Washington Post, October 20, 1995: A1.

World Trade Organization (WTO). 1995. Trading into the Future: WTO World Trade Organization. Geneva: WTO.